Long-term stability of liposomes containing both tissue-type plasminogen activator and glu-plasminogen

International Journal of Pharmaceutics

Volumn 129, Issue 1-2, 1996, Pages 191-202

  Heeremans, J L M ^a   Mijnheera, F W ^a   Gerritsen, H R ^a   Prevost, R ^a   Kluft, C ^b   Crommelin, D J A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Drug delivery system; Drug stability; Freeze drying; Liposomes; Plg; t PA

Indexed keywords

ALTEPLASE; LIPOSOME; PLASMINOGEN; PLASMINOGEN[GLUTAMIC ACID]; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG STORAGE; ENZYME ACTIVITY; FREEZE DRYING; PARTICLE SIZE; PRIORITY JOURNAL; ULTRACENTRIFUGATION;

EID: 0030000439     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04325-X     Document Type: Article

References (31)

1. Andreotti, F., Kluft, C., Hackett, D.R., Davies, G.J. and Maseri, A., Thrombin generation after fast or prolonged regimens of tissue-type plasminogen activator. Lancet, 342 (1993) 937-938.
2. Bangham, A.D., Standish, M.M. and Watkins, J.C., Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol., 13 (1965) 238-252.
3. Chapman, C.J., Erdahl, W.L., Taylor, R.W. and Pfeiffer, D.R., Factors effecting solute entrapment in phospholipid vesicles prepared by the freeze-thaw extrusion method: a possible general method for improving the efficiency of entrapment. Chem. Phys. Lipids, 55 (1990) 73-83.
4. Collen, D., Plasminogen activators and thrombolytic therapy. ISI Atlas of Science: Pharmacology, 1988, pp. 116-120.
5. Crommelin, D.J.A. and Schreier, H., Liposomes. In: Kreuter J. (Ed.), Colloidal drug delivery systems, Marcel Dekker Inc., New York, 1994, pp. 73-190.
6. Crowe, J.H. and Crowe, L.M., Preservation of liposomes by freeze-drying. In: Gregoriadis, G. (Ed.), Liposome Technology, liposome preparation and related techniques, CRC press, FL, Vol. I, 1993, pp. 229-252.
7. Crowe, J.H., Crowe, L.M., Carpenter, J.F. and Aurell Wistrom, C., Stabilization of dry phospholipid bilayers and proteins by sugars. Biochem. J., 242 (1987) 1-10.
8. Duncan, R.J.S., Weston, P.D. and Wrigglesworth, R., A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay. Anal. Biochem., 132 (1983) 68-73.
9. Friberger, P., Knos, M., Gustavsson, S., Aurell, L. and Claeson, G., Methods for the determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis, 7 (1978) 138-145.
10. Gaffney, P.J., Tissue plasminogen activator for thrombolytic therapy: expectation versus reality. J. R. Soc. Med., 85 (1992) 692-698.
11. Gram, J., Munkvad, S., Leebeek, F.W.G., Kluft, C. and Jespersen, J., Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activator. Cor. Art. Dis., 4 (1993) 371-377.
12. Grit, M., Zuidam, N.J. and Crommelin, D.J.A., Analysis and hydrolytic kinetics of phospholipids in aqueous liposome dispersions. In: Gregoriadis, G. (Ed.), Liposome Technology, CRC Press, FL, Vol. I, 1993a, pp. 455-486.
13. Grit, M., Zuidam, N.J., Underberg, W.J.M. and Crommelin, D.J.A., Hydrolysis of partially saturated egg phosphatidylcholine in aqueous liposome dispersions and the effect of cholesterol incorporation on its hydrolysis kinetics. J. Pharm. Pharmacol., 45 (1993b) 490-495.
14. Heeremans, J.L.M., Kraaijenga, J.J., Los, P., Kluft, C. and Crommelin, D.J.A., Development of a procedure for coupling the homing device glu-plasminogen to liposomes. Biochim. Biophys. Acta, 1117 (1992) 258-264.
15. Heeremans, J.L.M., Prevost, R., Bekkers, M.E.A., Los, P., Emeis, J.J., Kluft, C. and Crommelin, D.J.A., Thrombolytic treatment with tissue-type Plasminogen Activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA. Thromb. Haemostas., 73 (1995) 488-494.
16. Heeremans, J.L.M., Prevost, R., Bischot, L., Los, P., Kluft, C. and Crommelin, D.J.A., Interference of ε-amino-caproic acid with [N-succinimidyl S-acetylacetate derived] thiol introduction into glu-plasminogen. Fibrinolysis, 8 (1994) 138-141.
17. Hope, M.J., Bally, M.B., Mayer, L.D., Janoff, A.S. and Cullis, P.R., Generation of multilamellar and unilamellar phospholipid vesicles. Chem. Phys. Lipids, 40 (1986) 89-107.
18. Isele, U., van Hoogevest, P., Hilfiker, R., Capraro, H., Schieweck, K. and Leuenberger, H., Large-scale production of liposomes containing monomeric zinc phthalocyanine by controlled dilution of organic solvents. J. Pharm. Sci., 83 (1994) 1608-1616.
19. Martin, F.J. and Papahadjopoulos, D., Irreversible coupling of immuno-globulin fragments to preformed vesicles. J. Biol. Chem., 257 (1982) 286-288.
20. Mohler, M.A., Refino, C.J., Chen, A.B. and Hotchkiss, A.J., D-Phe-Pro-Arg-Chloromethylketone: its potential use in inhibiting the formation of in vitro artifacts in blood collected during tissue-type plasminogen activator thrombolytic therapy. Thromb. Haemostas., 56 (1986) 160-164.
21. Nguyen, T.H. and Ward, C., Stability characterization and formulation development of alteplase, a recombinant tissue plasminogen activator. In: Wang, Y.J. and Pearlman, R. (Eds.), Stability and characterization of protein and peptide drugs: case histories. Plenum Press, New York, 1993, Ch. 3, pp. 91-134.
22. Nieuwenhuizen, W., Fibrinogen and its specific sites for modulation of t-PA induced fibrinolysis. In: Kluft, C. (Ed.), Tissue-type Plasminogen Activator (t-PA): physiological and clinical aspects, CRC Press, FL, Vol. I, 1988, pp. 171-187.
23. Nieuwenhuizen, W., Verheijen, J.H., Vermond, A. and Chang, G.T.G., Plasminogen activation by tissue activator is accelerated in the presence of fibrin(ogen) cyanogen bromide fragment FCB-2. Biochim. Biophys. Acta, 755 (1983) 531-533.
24. Owen, J., Friedman, K.D., Grossman, B.A., Wilkins, C., Berke, A.D. and Powers, E.R., Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. Blood, 72 (1988) 616-620.
25. Özer, Y., Talsma, H. and Crommelin, D.J.A., Influence of freeze-drying on the stability of liposomes dispersed in aqueous media. Acta Pharm. Technol., 34 (1988) 129-139.
26. Radcliffe, R., A critical role for lysine residues in the stimulation of tissue-plasminogen activator by denatured proteins and fibrin clots. Biochim. Biophys. Acta, 743 (1983) 422-430.
27. Seitz, R., Blanke, H., Strauer, B.E. and Egbring, R., Increased thrombin activity during thrombolysis. Thromb. Haemostas., 59 (1988) 541-542.
28. Seitz, R., Pelzer, H., Immel, A. and Egbring, R., Prothrombin activation by thrombolytic agents. Fibrinolysis, 7 (1993) 109-115.
29. Talsma, H. and Crommelin, D.J.A., Liposomes as drug delivery systems. Pharm. Technol., 17 (1993) 48-59.
30. Talsma, H., van Steenbergen, M.J. and Crommelin, D.J.A., The cryopreservation of liposomes: 3. Almost complete retention of a water-soluble marker in small liposomes in a cryoprotectant containing dispersion after a freezing/thawing cycle. Int. J. Pharm., 77 (1991) 119-126.
31. Verheijen, J.H., Mullaart, E., Chang, G.T.G., Kluft, C. and Wijngaards, G., A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb. Haemostas., 48 (1982) 266-269.